Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594750 · ClinicalTrials.gov registry record
Mechanisms of Exacerbation of Asthma
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 67
- Enrollment target
NCT00594750: Clinical Trial study, sponsored by University of California, San Francisco.
NCT00594750 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 67 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00594750 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to identify the causes of asthma that were not previously suspected, to better understand the effects of inhaled steroids on asthma and to identify new way to treat asthma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2006-05 |
| Est. Completion | 2025-08-05 |
Why NCT00594750 stopped before completion
NCT00594750 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 67 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00594750 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00594750 about?
NCT00594750 is a clinical study titled "Mechanisms of Exacerbation of Asthma". The purpose of this study is to identify the causes of asthma that were not previously suspected, to better understand the effects of inhaled steroids on asthma and to identify new way to treat asthma.
What is the current status of trial NCT00594750?
This trial is currently terminated. The enrollment target is 67 participants. The study started on 2006-05. Estimated completion is 2025-08-05.
Who is sponsoring clinical trial NCT00594750?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia